Skip to main content

Table 4 Prevalence of Helicobacter pylori (H. pylori) antigen in different METAVIR fibrosis stages in patients with hepatitis C

From: Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C

Fibrosis stages H. pylori prevalence Odds ratio, P X2, P
Negative Positive
No fibrosis (F0) vs. fibrosis (F1‑F3)
 F0 (n = 95) 63 (66.32%) 32 (33.68%) 1.5, P > 0.05 2.3, P > 0.05
 F1‑F3 (n = 90) 50 (55.55%) 40 (44.45%)
Fibrosis (F1‑F3) vs. cirrhosis (F4)
 F1‑F3 (n = 90) 50 (55.55%) 40 (44.45%) 3.19, P = 0.001* 11.4, P = 0.001*
 F4 (n = 64) 18 (28.12%) 46 (71.88%)
Non cirrhosis (F0‑F3) vs. cirrhosis (F4)
 F0‑F3 (n = 185) 113 (61.08%) 72 (38.92%) 4.0, P < 0.0001* 20.71, P < 0.0001*
 F4 (n = 64) 18 (28.12%) 46 (71.88%)
  1. *P < 0.05 is considered significant